Henry Schein Stock Price, News & Analysis

Henry Schein, Inc. (NASDAQ: HSIC) is a solutions company for health care professionals that focuses on office-based dental and medical practitioners. The company describes itself as being powered by a network of people and technology, with a global organization of more than 25,000 "Team Schein Members" supporting its activities. Henry Schein states that its network of trusted advisors serves more than 1 million customers around the world.

According to the company, Henry Schein offers more than 300 valued solutions designed to help improve both operational success and clinical outcomes. These Business, Clinical, Technology, and Supply Chain solutions are aimed at helping office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. The company also notes that these solutions support dental laboratories, government and institutional health care clinics, and other alternate care sites.

Henry Schein operates within the medical, dental, and hospital equipment and supplies merchant wholesaler industry and is part of the broader wholesale trade sector. The company highlights that it operates through a centralized and automated distribution network, offering a selection of more than 300,000 branded products and Henry Schein corporate brand products in its distribution centers. This distribution capability underpins its role in supplying a broad range of health care products to professional customers.

The company reports that it is a FORTUNE 500 company and a member of the S&P 500® index, indicating that it is included in widely followed U.S. large-cap equity benchmarks. Henry Schein is headquartered in Melville, New York, and reports that it has operations or affiliates in 33 countries and territories. The company notes that its sales reached $12.7 billion in 2024 and that its sales have grown at a compound annual rate of approximately 11.2 percent since it became a public company in 1995. These figures are presented by Henry Schein as part of its long-term growth narrative.

Henry Schein reports its business through several reportable segments, as described in third-party classification data: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. The Global Distribution and Value-Added Services segment includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. The company has also highlighted Global Specialty Products and Global Technology as distinct areas of activity, reflecting specialty dental products and technology-focused offerings.

Within its Global Distribution and Value-Added Services activities, Henry Schein has described performance drivers such as global dental distribution merchandise and equipment, global medical distribution, and value-added services. In a recent financial update, the company discussed growth in dental merchandise and equipment, medical distribution, and consulting-related value-added services, indicating that these areas contribute to its overall sales and operating income performance.

Henry Schein emphasizes the role of technology and software in its health care solutions. Through its subsidiary Henry Schein One, the company is involved in dental practice management software and related services. Henry Schein One is described as a global provider of dental technology that helps dental practices optimize practice management, patient engagement, business management, and e-commerce activities. The Henry Schein One portfolio includes practice management brands such as Dentrix and Dentrix Ascend, as well as other software and analytics offerings.

Henry Schein One has announced initiatives around embedded artificial intelligence (AI) and automation in dental workflows. These initiatives include AI-enabled tools for documentation, imaging, forms, eligibility verification, and revenue cycle workflows within platforms such as Dentrix and Dentrix Ascend. The company has described capabilities such as AI-assisted clinical documentation, voice-enabled workflows, and AI-driven imaging analysis, which are intended to support dental teams in improving efficiency, accuracy, and patient communication. These technology activities sit within Henry Schein’s broader Global Technology segment.

In addition to technology, Henry Schein has highlighted partnerships and distribution agreements that expand its product offerings. For example, the company announced an expanded agreement with vVARDIS, granting Henry Schein exclusive U.S. distribution rights for the Curodont Repair Fluoride Plus product across all dental market segments, including general dentistry, orthodontics, and pediatric dentistry. Henry Schein reports that it is the market leader in selling Curodont to general practitioners and dental service organizations in the United States and that it serves as the exclusive distributor of the product in the United Kingdom, with non-exclusive rights in other jurisdictions.

Henry Schein also points to its centralized and automated distribution network as a core operational strength. The company notes that it maintains a selection of more than 300,000 branded and corporate brand products in its distribution centers, supporting its ability to supply dental and medical practitioners, laboratories, and institutional clinics. This distribution infrastructure is central to its role in the medical, dental, and hospital equipment and supplies merchant wholesaling industry.

From a capital markets perspective, Henry Schein’s common stock trades on the Nasdaq Global Select Market under the ticker symbol HSIC. The company has filed periodic reports and current reports on Form 8-K with the U.S. Securities and Exchange Commission, including filings related to financial results, leadership changes, and other material events. These filings provide additional detail on its operations, financial condition, and risk factors.

Henry Schein has also communicated elements of its long-term strategic focus. In a recent financial press release, the company referenced its BOLD+1 strategy and described investments in what it characterizes as high-growth, high-margin businesses within its portfolio. It has also discussed value creation initiatives that are intended to improve operating income over time, and it has highlighted a strategic partnership agreement with KKR Hawaii Aggregator L.P., which includes provisions related to KKR’s ownership stake in Henry Schein stock.

Leadership and governance developments are part of Henry Schein’s recent disclosures. The company announced that Stanley M. Bergman would retire as Chief Executive Officer while continuing to serve as Chairman of the Board, and later reported that Frederick M. Lowery has been appointed as the company’s next CEO, effective March 2, 2026, at which time he will join the Board of Directors. Henry Schein has indicated that this transition is intended to support a smooth leadership change and the continued execution of its strategic plans.

Business Segments and Activities

Based on company and third-party descriptions, Henry Schein’s activities can be grouped into several broad areas:

• Global Distribution and Value-Added Services: Distribution of national brand and Henry Schein corporate brand merchandise, equipment, and related technical services to dental and medical markets, along with value-added services such as consulting.
• Global Specialty Products: Specialty dental products, including areas such as dental implants and endodontics, which the company has cited as contributors to segment sales growth.
• Global Technology: Technology offerings that include practice management software, cloud-based platforms, revenue cycle management solutions, and AI-enabled tools delivered primarily through Henry Schein One.

These segments reflect Henry Schein’s combination of physical product distribution, specialty clinical products, and technology-based solutions for health care professionals.

Role in the Health Care Ecosystem

Henry Schein positions itself as a key partner to office-based dental and medical practitioners, dental laboratories, government and institutional health care clinics, and alternate care sites. By providing business, clinical, technology, and supply chain solutions, the company aims to support both the operational and clinical aspects of health care delivery in these settings. Its centralized distribution network and broad product selection are intended to ensure that practitioners have access to the supplies and equipment they need, while its technology platforms seek to streamline practice management and patient engagement.

FAQs about Henry Schein, Inc. (HSIC)

• What does Henry Schein, Inc. do?
  Henry Schein, Inc. is a solutions company for health care professionals that provides business, clinical, technology, and supply chain solutions. It focuses on office-based dental and medical practitioners and also supports dental laboratories, government and institutional health care clinics, and other alternate care sites.
• What industry is Henry Schein in?
  Henry Schein operates in the medical, dental, and hospital equipment and supplies merchant wholesaler industry within the wholesale trade sector. It distributes branded and Henry Schein corporate brand products through a centralized and automated distribution network.
• Who are Henry Schein’s primary customers?
  The company states that its network of trusted advisors serves more than 1 million customers globally. Primary customers include office-based dental and medical practitioners, dental laboratories, government and institutional health care clinics, and other alternate care sites.
• How does Henry Schein use technology in its business?
  Through its technology offerings, including those of its subsidiary Henry Schein One, the company provides dental practice management software, patient engagement tools, business management solutions, and e-commerce capabilities. It has also introduced AI-enabled and automated workflows for documentation, imaging, forms, eligibility, and revenue cycle processes within dental practice platforms.
• What are Henry Schein’s main business segments?
  Henry Schein’s reportable segments include Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. The Global Distribution and Value-Added Services segment includes distribution of merchandise, equipment, and related technical services to dental and medical markets, while Global Specialty Products and Global Technology focus on specialty clinical products and technology-based solutions, respectively.
• On which stock exchange is Henry Schein listed and what is its ticker symbol?
  Henry Schein’s common stock is listed on the Nasdaq Global Select Market under the ticker symbol HSIC.
• Where is Henry Schein headquartered?
  The company reports that it is headquartered in Melville, New York, and that it has operations or affiliates in 33 countries and territories.
• Is Henry Schein part of any major stock indices?
  Henry Schein states that it is a FORTUNE 500 company and a member of the S&P 500® index.
• How large is Henry Schein’s product offering?
  Henry Schein reports that it operates a centralized and automated distribution network with a selection of more than 300,000 branded products and Henry Schein corporate brand products in its distribution centers. It also notes that it offers more than 300 valued solutions to its customers.
• What recent leadership changes has Henry Schein announced?
  The company has disclosed that Stanley M. Bergman will retire as Chief Executive Officer while continuing as Chairman of the Board. It has also announced the appointment of Frederick M. Lowery as its next CEO, effective March 2, 2026, at which time he will join the Board of Directors.